Xcout Intel
Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Subscribe to see Sagimet Biosciences Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sagimet Biosciences Inc. at a glance
Sagimet Biosciences Inc. is a biotech company headquartered in San Mateo, United States. It is publicly listed (SGMT) with a market capitalisation of $236.9M. Xcout tracks 23 named people at Sagimet Biosciences Inc., including David A. Happel (Chief Executive Officer, President & Director).
Sagimet Biosciences Inc. leadership
- David A. HappelChief Executive Officer, President & Director
- David HappelChief Executive Officer
- Thierry ChaucheChief Financial Officer & Principal Accounting Officer
- Elizabeth RozekChief Legal & Administrative Officer
- Andreas GrauerChief Medical Officer
- Marie O'FarrellChief Scientific Officer
17 more named people on record for Sagimet Biosciences Inc., with roles, board committees and tenure — see the full roster →
Get Sagimet Biosciences Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sagimet Biosciences Inc. in Xcout Intel
- 23 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access